Skip to content

Glycemic control in children with type 1 diabetes

Comparison of two methods of carbohydrate counting and fixed-dose insulin in glycemic control in children with type 1 diabetes

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT20231016059738N1
Enrollment
76
Registered
2023-11-05
Start date
2023-11-21
Completion date
Unknown
Last updated
2023-11-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 1 diabetes. Type 1 diabetes mellitus without complications

Interventions

Intervention 1: Intervention group: Patients are randomly assigned to the group under sugar control intervention with carbohydrate counting method to determine mealtime insulin. Finally, the changes o

Sponsors

Tehran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
6 Years to 18 Years

Inclusion criteria

Inclusion criteria: Type 1 diabetes patients 6 to 18 years old, who have been diagnosed for at least six months Treated with insulin They are not in the honeymoon period Have been subjected to basic training in terms of diabetic diet

Exclusion criteria

Exclusion criteria: Underlying diseases such as liver or kidney failure A history of feeding through a digestive tube Failure to provide written consent to enter the study

Design outcomes

Primary

MeasureTime frame
Glucose level. Timepoint: At the beginning of the study and after the intervention. Method of measurement: Paraclinic – Laboratory.;HbA1c. Timepoint: At the beginning of the study and after the intervention. Method of measurement: Paraclinic – Laboratory.;The Total Amount Of Insulin Received Daily. Timepoint: At the beginning of the study and after the intervention. Method of measurement: Questionnaire-Clinical File.;Cholesterol. Timepoint: At the beginning of the study and after the intervention. Method of measurement: Paraclinic – Laboratory.;Triglyceride. Timepoint: At the beginning of the study and after the intervention. Method of measurement: Paraclinic – Laboratory.;HDL. Timepoint: At the beginning of the study and after the intervention. Method of measurement: Paraclinic – Laboratory.;LDL. Timepoint: At the beginning of the study and after the intervention. Method of measurement: Paraclinic – Laboratory.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactShadi Niliyeh

Tehran University of Medical Sciences

shadi.niliyeh65@googlemail.com00982161479

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026